The diminished function and depletion of CD8(+) tumor-infiltrating lymphocytes is a key barrier to immunotherapy in the treatment of cancer patients, and hypoxia is one of the main causes of diminished CD8(+) T-cell function (48). Here, CD8A is linked to neoplasm.